Estrogens < Etanercept < Ethambutol

Facettes : Author.f AffPays.f Mesh.f AffRegion.f AffVille.f AffOrg.f

List of bibliographic references

Number of relevant bibliographic references: 144.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000010 (2020)	Seoyoung C. Kim [États-Unis] ; Sebastian Schneeweiss [États-Unis]	When Randomized Clinical Trials and Real-World Evidence Say the Same: Tocilizumab and Its Cardiovascular Safety.
000213 (2020)	Jon T. Giles [États-Unis] ; Naveed Sattar [Royaume-Uni] ; Sherine Gabriel [États-Unis] ; Paul M. Ridker [États-Unis] ; Steffen Gay [Suisse] ; Charles Warne [Royaume-Uni] ; David Musselman [États-Unis] ; Laura Brockwell [Royaume-Uni] ; Emma Shittu [Royaume-Uni] ; Micki Klearman [États-Unis] ; Thomas R. Fleming [États-Unis]	Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial.
000260 (2019)	Nienke M. Ter Haar [Pays-Bas] ; E H Pieter Van Dijkhuizen [Pays-Bas] ; Joost F. Swart [Pays-Bas] ; Annet Van Royen-Kerkhof [Pays-Bas] ; Ayman El Idrissi [Pays-Bas] ; Arjen P. Leek [Pays-Bas] ; Wilco De Jager [Pays-Bas] ; Mark C H. De Groot [Pays-Bas] ; Saskia Haitjema [Pays-Bas] ; Dirk Holzinger [Allemagne] ; Dirk Foell [Allemagne] ; Jorg Van Loosdregt [Pays-Bas] ; Nico M. Wulffraat [Pays-Bas] ; Sytze De Roock [Pays-Bas] ; Sebastiaan J. Vastert [Pays-Bas]	Treatment to Target Using Recombinant Interleukin-1 Receptor Antagonist as First-Line Monotherapy in New-Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five-Year Follow-Up Study.
000345 (2019)	Natalia Cabrera [France] ; Jean-Christophe Lega [France] ; Behrouz Kassai [France] ; Carine Wouters [Belgique] ; Anuela Kondi [France] ; Elvira Cannizzaro [Suisse] ; Andreas Woerner [Suisse] ; Aurelie Chausset [France] ; Samuel Roethlisberger [Suisse] ; Cyril Jeanneret [Suisse] ; Florence Aeschlimann [Suisse] ; Salma Malik [France] ; Agnès Duquesne [France] ; Daniela Kaiser [Suisse] ; Laetitia Higel [France] ; Anne Maes [Belgique] ; Gerald Berthet [Suisse] ; Veronique Hentgen [France] ; Isabelle Kone-Paut [France] ; Alexandre Belot [France] ; Michael Hofer [Suisse]	Safety of biological agents in paediatric rheumatic diseases: A real-life multicenter retrospective study using the JIRcohorte database.
000357 (2019)	Emma L. Simpson [Royaume-Uni] ; Shijie Ren [Royaume-Uni] ; Emma S. Hock [Royaume-Uni] ; John W. Stevens [Royaume-Uni] ; Aymeric Binard [France] ; Yves-Marie Pers [France] ; Rachel Archer [Royaume-Uni] ; Suzy Paisley [Royaume-Uni] ; Matthew D. Stevenson [Royaume-Uni] ; Chloé Herpin [France] ; Salah Ghabri [France]	Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis.
000371 (2019)	Tomoyuki Mutoh [Japon] ; Tomonori Ishii [Japon] ; Tsuyoshi Shirai [Japon] ; Kanae Akita [Japon] ; Yukiko Kamogawa [Japon] ; Yoko Fujita [Japon] ; Hiroko Sato [Japon] ; Yuko Shirota [Japon] ; Hiroshi Fujii [Japon] ; Hideo Harigae [Japon]	Refractory Takayasu arteritis successfully treated with rituximab: case-based review.
000387 (2019)	Meghna Jani [Royaume-Uni] ; Anne Barton [Royaume-Uni] ; Kimme Hyrich [Royaume-Uni]	Prediction of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification?
000400 (2019)	G. Carlino [Italie] ; M. Fornaro ; L. Santo ; R. Bucci ; A. Semeraro ; L. Quarta ; F. D'Onofrio ; A. Marsico ; C. Zuccaro ; P C Falappone ; D. Mazzotta ; F P Cantatore ; M. Muratore ; F. Iannone	Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE).
000411 (2019)	Moshe C. Ornstein [États-Unis] ; Cassandra Calabrese [États-Unis] ; Laura S. Wood [États-Unis] ; Elizabeth Kirchner [États-Unis] ; Pamela Profusek [États-Unis] ; Kimberly D. Allman [États-Unis] ; Allison Martin [États-Unis] ; Apostolos Kontzias [États-Unis] ; Petros Grivas [États-Unis] ; Jorge A. Garcia [États-Unis] ; Leonard H. Calabrese [États-Unis] ; Brian I. Rini [États-Unis]	Myalgia and Arthralgia Immune-related Adverse Events (irAEs) in Patients With Genitourinary Malignancies Treated With Immune Checkpoint Inhibitors.
000426 (2019)	Francisco Airton Castro Rocha [Brésil] ; Joaquim Ivo Vasques Dantas Landim [Brésil] ; Mariana Lima Nour [Brésil] ; Valdenir Freire Peixoto Filho [Brésil] ; Leila Nascimento Da Rocha [Brésil] ; Marco Felipe Castro Da Silva [Brésil] ; Hermano Alexandre Lima Rocha [Brésil]	Long-term breastfeeding influences disease activity in a low-income juvenile idiopathic arthritis cohort.
000479 (2019)	Francisco Airton Castro Rocha [Brésil] ; Joaquim Ivo Vasques Dantas Landim [Brésil] ; Marcela Gondim Aguiar [Brésil] ; João Pedro Emrich Accioly [Brésil] ; Carolina Noronha Lechiu [Brésil] ; Luiza Helena Acácio Costa [Brésil] ; Carlos Nobre Rabelo Júnior [Brésil] ; Leila Nascimento Da Rocha [Brésil] ; Hermano Alexandre Lima Rocha [Brésil]	Evaluation of disease activity in a low-income juvenile idiopathic arthritis cohort.
000500 (2019)	Noemi Muszbek [Royaume-Uni] ; Clare Proudfoot [Royaume-Uni] ; Marie Fournier [France] ; Chieh-I Chen [États-Unis] ; Andreas Kuznik [États-Unis] ; Zsofia Kiss [Royaume-Uni] ; Peter Gal [Hongrie] ; Kaleb Michaud [États-Unis]	Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs.
000504 (2019)	Masakazu Kondo [Japon] ; Hisakata Yamada [Japon]	Drug survival rates of biological disease-modifying antirheumatic drugs and Janus kinase-inhibitor therapy in 801 rheumatoid arthritis patients: a 14 year-retrospective study from a rheumatology clinic in Japan.
000532 (2019)	Katsuhiko Takabayashi [Japon] ; Fumihiko Ando [États-Unis] ; Takahiro Suzuki [Japon]	Comparing the effectiveness of biological disease-modifying antirheumatic drugs using real-world data.
000700 (2018)	Elodie Rivière [France] ; Jérémie Sellam [France] ; Juliette Pascaud [France] ; Philippe Ravaud [France] ; Jacques-Eric Gottenberg [France] ; Xavier Mariette [France]	Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis.
000702 (2018)	Andrew I. Rutherford [Royaume-Uni] ; Sujith Subesinghe [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni] ; James B. Galloway [Royaume-Uni]	Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
000716 (2018)	Gablu Kilcher [Suisse] ; Noemi Hummel [Suisse] ; Eva M. Didden [Suisse] ; Matthias Egger [Suisse] ; Stephan Reichenbach [Suisse]	Rheumatoid arthritis patients treated in trial and real world settings: comparison of randomized trials with registries.
000747 (2018)	Lluís Puig [Espagne]	Paradoxical Reactions: Anti-Tumor Necrosis Factor Alpha Agents, Ustekinumab, Secukinumab, Ixekizumab, and Others.
000794 (2018)	Neide Tomimura Costa [Brésil] ; Tatiana Mayumi Veiga Iriyoda [Brésil] ; Daniela Frizon Alfieri [Brésil] ; Andréa Name Colado Simão [Brésil] ; Isaias Dichi [Brésil]	Influence of disease-modifying antirheumatic drugs on oxidative and nitrosative stress in patients with rheumatoid arthritis.
000868 (2018)	Shingo Nakayamada [Japon] ; Satoshi Kubo [Japon] ; Maiko Yoshikawa [Japon] ; Yusuke Miyazaki [Japon] ; Naoki Yunoue [Japon] ; Shigeru Iwata [Japon] ; Ippei Miyagawa [Japon] ; Shintaro Hirata [Japon] ; Kazuhisa Nakano [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon]	Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis.
000885 (2018)	Ettore Silvagni [Italie] ; Alessandra Bortoluzzi [Italie] ; Greta Carrara [Italie] ; Anna Zanetti [Italie] ; Marcello Govoni [Italie] ; Carlo Alberto Scirè [Italie]	Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Etanercept" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Etanercept" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Etanercept
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021